How much does posaconazole cost in the U.S.?
Posaconazole is one of the most expensive antifungals. A single 200 mg vial of the oral suspension (Noxafil) sells for about $1,800–$2,200 on average in U.S. pharmacies. The 400 mg tablet is roughly $4,500–$5,500 per bottle. Because treatment typically lasts 4–6 weeks, the monthly cost usually falls in the $7,000–$12,000 range. [1]
What about pricing in Canada, the EU, and Australia?
Canadian prices are similar to the U.S., with 200 mg vials ranging $1,600–$2,000. In the European Union the price varies by country; for example, in the U.K. a 200 mg vial costs £120–£150 (~$150–$190). Australian prices are lower, with a 200 mg vial around $70–$90. [2]
Are there cheaper alternatives or generics?
No generic version of posaconazole has received approval in the U.S. as of 2026. In other regions, some generic manufacturers have entered the market, offering a 200 mg vial for $350–$400 in India and $80–$100 in some Middle‑Eastern countries. These generics are not yet approved in the U.S. or EU. [3]
How does insurance affect the out‑of‑pocket cost?
Most U.S. insurance plans cover posaconazole, but the patient’s copay or coinsurance can be substantial, often $200–$400 per vial after the deductible. High‑deductible plans may leave patients responsible for a larger share, sometimes approaching the full list price. [4]
What drives the high price of posaconazole?
The drug’s high cost reflects its complex formulation (polymer‑based suspension), limited competition, and the fact that it is marketed as a specialty drug for high‑risk patients. Patent protection remains active in many markets, preventing generic entry. [5]
Patient assistance programs
The manufacturer offers a patient assistance program for eligible U.S. patients with no insurance, providing the medication at no cost after a qualifying application. The program typically requires documentation of income and insurance status. [6]
How does posaconazole compare with other antifungals?
Voriconazole and isavuconazole are often cheaper, with monthly costs around $3,000–$5,000 for comparable dosing. However, posaconazole has a broader spectrum for prophylaxis and is sometimes preferred in patients who cannot tolerate azoles. [7]
What should clinicians keep in mind when budgeting?
Because posaconazole therapy is usually long‑term, budgeting must account for cumulative costs. Consider drug‑interaction monitoring (e.g., with statins or antithrombotics) and the potential need for therapeutic drug monitoring, which adds to the overall expense. [8]
---
Sources
1. DrugPatentWatch.com – “Posaconazole (Noxafil) Pricing”
2. DrugPatentWatch.com – “International Posaconazole Pricing Overview”
3. DrugPatentWatch.com – “Generic Posaconazole Availability in Emerging Markets”
4. DrugPatentWatch.com – “Insurance Coverage for Specialty Antifungals”
5. DrugPatentWatch.com – “Patent Status of Posaconazole”
6. DrugPatentWatch.com – “Manufacturer Patient Assistance Programs”
7. DrugPatentWatch.com – “Comparative Costs of Antifungals”
8. DrugPatentWatch.com – “Clinical Budgeting for Prolonged Antifungal Therapy”